Table 5.
Characteristics | Univariable Analysis | Multivariable Analysis | |||||
---|---|---|---|---|---|---|---|
5-Years OS (%) | Median OS (Months) | p Values | HR | 95% C.I. | p Values | ||
Age, years | <70 | 41.9 | 49.4 | 0.081 | |||
≥70 | 27.4 | 38.7 | |||||
Gender | M | 30.3 | 43.9 | 0.120 | |||
F | 43.3 | 51.3 | |||||
Type of BTC | ICC | 42.7 | 50.1 | <0.001 | ref | 0.002 | |
PCC | 31.8 | 41.8 | 1.512 | 1.016–2.295 | 0.048 | ||
DCC | 37.2 | 31.2 | 0.935 | 0.461–1.895 | 0.935 | ||
GBC | 20.7 | 18.6 | 2.698 | 1.580–4.606 | <0.001 | ||
Preoperative ChT | No | 35.5 | 43.1 | 0.793 | |||
Yes | 38.1 | 46.5 | |||||
AJCC 8th T Stage | T1–2 | 48.1 | 55.7 | <0.001 | 1.515 | 1.076–2.352 | 0.014 |
T3–4 | 23.8 | 30.4 | |||||
AJCC 8th N Stage | N0 | 53.4 | 64.9 | <0.001 | 2.431 | 1.613–3.664 | <0.001 |
N1–N2 | 12.8 | 26.3 | |||||
Histologic grading | G1–2 | 36.9 | 48.5 | 0.002 | 1.494 | 1.008–2.213 | 0.045 |
G3–4 | 28.5 | 26.9 | |||||
Radicality | R0 | 38.2 | 48.8 | 0.006 | 1.108 | 0.746–1.647 | 0.611 |
R1 | 32.1 | 32.8 | |||||
Macrovascular invasion | No | 39.0 | 48.8 | <0.001 | 1.335 | 0.894–1.991 | 0.157 |
Yes | 27.4 | 26.6 | |||||
Postoperative ChT | No | 35.0 | 43.1 | 0.654 | |||
Yes | 37.3 | 48.1 | |||||
LMR | ≥3.47 | 39.6 | 48.8 | 0.004 | 1.378 | 1.046–2.007 | 0.025 |
<3.47 | 33.2 | 32.8 |
BTC, biliary tract cancer; ChT, chemotherapy; AJCC, American Joint Committee against Cancer; PBD, preoperative biliary drainage; LMR, lymphocyte to monocyte ratio.